|3.||Liver Diseases (Liver Disease)
|1.||Centers for Disease Control and Prevention (CDC): 12 articles (02/2015 - 09/2001)|
|2.||Van Damme, Pierre: 11 articles (10/2015 - 01/2004)|
|3.||Yokosuka, Osamu: 9 articles (01/2014 - 08/2004)|
|4.||Van Damme, P: 8 articles (01/2012 - 09/2000)|
|5.||Wakita, Takaji: 7 articles (12/2014 - 11/2005)|
|6.||Bell, Beth P: 7 articles (02/2011 - 10/2003)|
|7.||Fujiwara, Keiichi: 7 articles (02/2011 - 08/2004)|
|8.||Van Herck, Koen: 6 articles (10/2015 - 01/2004)|
|9.||Gilca, Vladimir: 6 articles (01/2014 - 01/2006)|
|10.||Imazeki, Fumio: 6 articles (01/2010 - 06/2005)|
05/07/2004 - "Both vaccines have been shown highly effective in preventing viral hepatitis A in former studies."
02/01/2012 - "Vaccines for hepatitis A, B and HPV have been highly effective in controlling STI at a community level."
10/01/2003 - "These vaccines are safe, highly immunogenetic and induce long lasting (> 20 years) protection against hepatitis A. "
07/01/2009 - "Improved health education to increase awareness about the risk of these diseases and appropriate immunisations, particularly hepatitis A and B vaccines, could play an important role."
12/01/2007 - "These vaccines offer a single injection for satisfactory protection against hepatitis A and B and an excellent safety and reactogenicity profile in comparison with monovalent vaccines. "
|2.||Hepatitis A Vaccines (Hepatitis A Vaccine)IBA
01/01/2009 - "Hepatitis A vaccines have been highly effective in preventing hepatitis A. "
10/25/2007 - "Hepatitis A vaccine administered to persons after exposure to the hepatitis A virus has not been compared directly with immune globulin, which is known to be highly effective in preventing hepatitis A when given within 2 weeks after exposure to the virus. "
02/01/2004 - "Improved understanding of the epidemiology and transmission of hepatitis A combined with the availability of effective hepatitis A vaccines have dramatically reduced the burden of hepatitis A in the United States."
08/13/1992 - "The inactivated purified hepatitis A vaccine that we tested is well tolerated, and a single dose is highly protective against clinically apparent hepatitis A."
10/29/2014 - "Benefiting from the booming economy, rapid improvement in sanitation, safe water supply, and implementation of hepatitis A vaccines, the epidemiological pattern of hepatitis A moved from high to intermediate endemicity in Shijiazhuang. "
01/01/2009 - "Immunoglobulins seem to be effective for pre-exposure and post-exposure prophylaxis of hepatitis A. "
03/01/1995 - "Pre- and postexposure immunization with pooled human serum immunoglobulin (ISG) is approximately 90% effective in preventing hepatitis A. "
07/01/1991 - "Use of immunoglobulin is effective in controlling outbreaks and preventing hepatitis A among travellers. "
01/01/1983 - "Standardization will assure the continued and consistent efficacy of immunoglobulin batches for prophylaxis against hepatitis A."
05/01/1996 - "The efficacy of immunoglobulin serum in the prevention of hepatitis A has been demonstrated since 1944. "
04/01/2009 - "The combined hepatitis A and B vaccine Twinrix proved to be highly effective against HBV, although antibody concentrations and seroprotection rates decreased with increasing age."
06/01/2004 - "Twinrix (GlaxoSmithKline), a combined vaccine providing protection against both hepatitis A and B, has been available in more than 72 countries worldwide since 1997. "
05/01/2007 - "A combined vaccine providing dual protection against hepatitis A and B is available (Twinrix, GlaxoSmithKline Biologicals). "
02/01/2003 - "Twinrix (GlaxoSmithKline Biologicals, Rixensart, Belgium) is the first combined vaccine to provide protection against both hepatitis A and B. "
03/26/1999 - "A vaccine providing dual protection against hepatitis A and B is now available (Twinrix, SmithKline Beecham Biologicals). "
|5.||Hepatitis A AntibodiesIBA
01/01/2008 - "To estimate the prevalence of anti-HAV-T in the group of HIV-positive adults and to assess the efficacy of vaccination against viral hepatitis A. "
07/01/1995 - "[The efficacy of the prevaccination detection of anti-HAV in hepatitis A vaccination programs]."
04/01/1985 - "Positive results of anti-HAV were obtained in the early stage after the onset of hepatitis A. "
08/01/2005 - "A prospective trial was performed to detect seroprevalence of maternal hepatitis A antibodies during the first 2 years of life among young infants born to hepatitis A antibody positive mothers in Turkey. "
08/01/2000 - "Wastewater workers in this study had a higher prevalence of anti-HAV than drinking water workers, which suggested that wastewater workers may have been at increased risk of occupationally acquired hepatitis A. "
|6.||Immunoglobulin M (IgM)IBA
05/01/1996 - "Only patients with acute hepatitis A produced a significant number of false positives by the enterovirus ELISA (12 out of 20), but the reverse was not true: patients with enterovirus IgM did not produce false positive results in tests for hepatitis A IgM. "
12/01/1983 - "False positive results occurring in a radioimmunoassay for hepatitis A IgM antibody of the IgM class."
05/01/2012 - "During the study period, there were 111 patients with positive hepatitis A IgMs, 154 with acute hepatitis A ICD-9 codes, and 77 with positive IgM and elevated liver function tests. "
10/01/2011 - "Coexistence of IgM antihepatitis A virus and IgM antihepatitis E virus in acute viral hepatitis: a prospective, multicentre study in Korea."
03/15/1999 - "Methods included study of notifications to the Ministry of Health or hospitalizations of cases of hepatitis A and of positive laboratory tests results (IgM) for hepatitis A. "
12/10/1999 - "This may be important for protection against hepatitis A, and suggests that recall memory for HAV antigen is elicited by the vaccine."
11/01/1991 - "The TRFIA may be used effectively both for control of the antigen amplification in HAV-infected cell culture and for early diagnosis of acute forms of viral hepatitis A."
12/01/2011 - "The application of vaccinia virus vector in hepatitis A antigen preparation was very useful and promising."
02/01/2004 - "This study shows a substantial immune response to re-exposure to hepatitis A antigen after 12 years, which occurs rapidly to ensure protection within the average incubation period of hepatitis A virus."
01/01/2003 - "The 1988-2000 laboratory studies of water objects in the Perm Region revealed a significant contamination of household effluents, underground and superficial water sources and distribution network water with hepatitis A antigen, Coxsackie and ECHO enteroviruses, and rotavirus antigen. "
08/25/1966 - "[Studies on the efficacy of prophylactic gamma globulin in infectious hepatitis in institutions for children]."
10/01/1972 - "[Efficacy of gamma globulin and albumin in preventing infectious hepatitis]."
10/01/1963 - "EFFICACY OF VARIED DOSES OF GAMMA GLOBULIN DURING AN EPIDEMIC OF INFECTIOUS HEPATITIS, HOONAH, ALASKA, 1961."
03/01/1956 - "The efficacy of gamma globulin in the control of an epidemic of infectious hepatitis."
12/27/1951 - "PROTECTION against epidemic (infectious) hepatitis with gamma globulin."
|9.||Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
03/01/1989 - "We assessed in a western population the efficacy of a plasma-derived hepatitis B vaccine in relatives of highly infectious hepatitis B virus (HBV) carriers. "
04/01/2013 - "This study demonstrated that the immunization effects of booster vaccination with combined hepatitis A and hepatitis B vaccine is successful for children. "
01/01/2008 - "Overall, analyses that evaluated the combined hepatitis A/hepatitis B vaccine, adjusted incidence for under-reporting, included societal costs and that came from studies of higher methodological quality tended to have more attractive cost-effectiveness ratios. "
01/01/2007 - "Studies have confirmed that hepatitis A and hepatitis B vaccines are safe and immunogenic in patients in these populations, although patients with more advanced disease may respond less well. "
01/01/2002 - "Two hundred forty-eight study subjects were allocated to two study groups and received either two doses of the combined hepatitis A and B vaccine (68% of subjects) or the corresponding monovalent hepatitis A and hepatitis B vaccines (32% of subjects) concomitantly in opposite arms. "
08/01/1999 - "Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial."
01/29/1994 - "Interferon for hepatitis A."
01/01/1994 - "[The interferon system and natural cytotoxicity functions in patients with acute viral hepatitis A and B]."
10/01/1992 - "Interferon therapy for non-A, non-B hepatitis: a pilot study and review of the literature."
08/01/1990 - "Interferon as treatment for viral hepatitis: a progress report."
07/27/2001 - "Safety and efficacy of hepatitis A vaccination in liver transplantation recipients."
01/01/2010 - "Management of hepatitis A includes general supportive care, and critical decisions regarding liver transplantation await further studies on prognostic predictors. "
10/01/1997 - "Therefore, the current study was conducted retrospectively in a single French urban pediatric liver transplantation center to serve as a reminder of the potential severity of hepatitis A in children and to identify predictors of outcome. "
11/01/2008 - "Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain."
06/01/2006 - "We present a patient diagnosed with fulminant hepatitis A referred for liver transplantation. "
|2.||Drug Therapy (Chemotherapy)
09/01/1995 - "IFN-alpha emerged, from the present study, as a promising candidate for chemotherapy of severe forms of hepatitis A."
01/01/1994 - "Recombinant IFN-alpha emerged, from the present study, as a promising candidate for chemotherapy of hepatitis A."
08/01/2002 - "Textword and MeSH searches for hepatitis A, B, C, D, E, G, delta, GB virus, GBV-C, and TT virus were linked to searches under the textword terms sex$, prevent$, and MeSH subheadings, microbiology, complications, drug therapy, therapy, diagnosis, epidemiology, transmission, and prevention and control. "
10/01/1969 - "[Drug therapy affecting thrombelastographic parameters in infectious hepatitis in children]."
06/01/1992 - "Serological markers of hepatitis A, B, and Delta and human immunodeficiency viruses were studied in 25 children receiving cancer chemotherapy. "
01/01/1994 - "International travel to hepatitis A endemic areas and illicit parenteral drug use were less frequently documented risk factors, although illicit injectable drug use has been considered more significant in other hepatitis A studies. "
12/01/1994 - "In comparison with the classical immunisation schedules (0-1-6 or 0-1-12 months) for hepatitis A, a 0- and 12- or a 0- and 6-month schedule would have important advantages by reducing the number of injections and discomfort and increasing scheduling convenience and patient compliance. "
05/01/1974 - "Hepatic wash-out curves of 85Kr and 133Xe after retrograde hepatic venous injections in patients with infectious hepatitis and in controls."
01/01/1996 - "They include variable schemes according to the vaccinal doses (hepatitis A, B, diphteria) or the number of injections (hepatitis A, B, rabies). "
08/01/1980 - "Infectious hepatitis was transmitted mainly through every day contacts, while the leading factor in the transmission of serum hepatitis consisted in various injections. "
|4.||Transplantation (Transplant Recipients)
06/01/2014 - "Efficacy and safety of hepatitis A vaccination in kidney transplant recipients."
04/01/2013 - "Are liver transplant recipients protected against hepatitis A and B?"
04/01/1980 - "The question whether these findings are an extreme form of the common pathological changes seen in the liver in other transplant recipients, or were related to infectious hepatitis or were due to the use of immunosuppressive therapy, remains unanswered."
05/01/2012 - "Despite effective vaccine available, hepatitis A remains a significant cause of morbidity and mortality worldwide including acute liver failure, transplantation and death. "
11/01/2008 - "The acute type FH, which has a disease duration as 10 days or shorter before the development of encephalopathy (onset-coma days [OCD]), mainly consists of hepatitis A and B and has relatively better prognosis, with an approximately 40% survival rate without transplantation. "
|5.||Day Care (Partial Hospitalization)
12/01/2001 - "Although outbreaks of hepatitis A were common events in day-care centres in north Queensland during the two-year study period, a single case of hepatitis A associated with a centre was a poor predictor of an outbreak within that centre. "
12/03/2014 - "We investigated an outbreak of hepatitis A in two day care centres and found that a large proportion (23%) of the 113 unvaccinated preschool children were immune to HAV. "
01/01/2007 - "Three hundred nineteen cases of hepatitis A illness during the years 1993 through 2005 were associated with 113 outbreaks in day care and school settings of which 92% occurred before the institution of universal toddler immunization. "
01/01/2007 - "The records of all hepatitis A illness outbreaks in day care and school settings reported to the Ministry of Health in Southern Israel during 1993 through 2005 were reviewed. "
01/01/2007 - "The effect of the Israeli program on outbreaks of Hepatitis A in day care and school settings was studied. "